Evidence map›Paper›PMID 26391536›Full record

ArticleJournal of thrombosis and haemostasis : JTH2015

Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.

L Deforche, E Roose, A Vandenbulcke, N Vandeputte, H B Feys, T A Springer, L Z Mi, J Muia, J E Sadler, K Soejima and 4 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues.Mediterranean journal of hematology and infectious diseases · 2024
    Review
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

L DeforcheLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
E RooseLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
A VandenbulckeLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
N VandeputteLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
H B FeysTransfusion Research Center, Belgian Red Cross Flanders, Gent, Belgium.
T A SpringerProgram in Cellular and Molecular Medicine, Boston Children's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
L Z MiProgram in Cellular and Molecular Medicine, Boston Children's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
J MuiaDepartments of Medicine, Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
J E SadlerDepartments of Medicine, Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.
K SoejimaResearch Department 1, The Chemo-Sero-Therapeutic Research Institute, Kikuchi, Kumamoto, Japan.
H RottensteinerBaxter Innovations GmbH, Vienna, Austria.
H DeckmynLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
S F De MeyerLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
K VanhoorelbekeLaboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
KU Leuven · BEBoston Children's Hospital · USWashington University in St. Louis · USBaxter (Austria) · ATCrossLang (Belgium) · BEKaketsuken (Japan) · JP

Funding

PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGYT32HL007088 · NHLBI · WASHINGTON UNIVERSITY · PI Grant Anthony Challen, Stephen Oh · 1985 to 2026
$14.1M
Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
VON WILLEBRAND FACTOR MULTIMER ASSEMBLY AND STRUCTURER01HL072917 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2003 to 2012
$4.4M
Regulation of ADAMTS13 ActivityR01HL089746 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2007 to 2011
$2.1M
ALLOSTERIC REGULATION OF ADAMTS13R01HL130446 · NHLBI · WASHINGTON UNIVERSITY · PI KORNFELD, STUART A · 2016 to 2019
$1.7M
NHLBI NIH HHS R01 HL072917NHLBI NIH HHS R01 HL089746NHLBI NIH HHS R01 HL130446NHLBI NIH HHS R01 HL72917NHLBI NIH HHS R01 HL89746NHLBI NIH HHS T32 HL007088NHLBI NIH HHS U54 HL112303
6 · The paper itself

Abstract

backgroundRecently, conformational activation of ADAMTS-13 was identified. This mechanism showed the evolution from a condensed conformation, in which the proximal MDTCS and distal T2-CUB2 domains are in close contact with each other, to an activated, open structure due to binding with von Willebrand factor (VWF).

objectivesIdentification of cryptic epitope/exosite exposure after conformational activation and of sites of flexibility in ADAMTS-13.

methodsThe activating effect of 25 anti-T2-CUB2 antibodies was studied in the FRETS-VWF73 and the vortex assay. Cryptic epitope/exosite exposure was determined with ELISA and VWF binding assay. The molecular basis for flexibility was hypothesized through rapid automatic detection and alignment of repeats (RADAR) analysis, tested with ELISA using deletion variants and visualized using electron microscopy.

resultsEleven activating anti-ADAMTS-13 antibodies, directed against the T5-CUB2 domains, were identified in the FRETS-VWF73 assay. RADAR analysis identified three linker regions in the distal domains. Interestingly, identification of an antibody recognizing a cryptic epitope in the metalloprotease domain confirmed the contribution of these linker regions to conformational activation of the enzyme. The proof of flexibility around both the T2 and metalloprotease domains, as shown by by electron microscopy, further supported this contribution. In addition, cryptic epitope exposure was identified in the distal domains, because activating anti-T2-CUB2 antibodies increased the binding to folded VWF up to ~3-fold.

conclusionConformational activation of ADAMTS-13 leads to cryptic epitope/exosite exposure in both proximal and distal domains, subsequently inducing increased activity. Furthermore, three linker regions in the distal domains are responsible for flexibility and enable the interaction between the proximal and the T8-CUB2 domains.

Indexed as

ADAM ProteinsADAMTS13 ProteinAllosteric RegulationAllosteric SiteAmino Acid SequenceAntibodies, MonoclonalAntigen-Antibody ReactionsCatalysisConsensus SequenceEnzyme ActivationEpitopesHumansMicroscopy, ElectronMolecular Sequence DataProtein BindingProtein ConformationADAM ProteinsADAMTS13 ProteinADAMTS13 protein, humanAntibodies, MonoclonalEpitopesThrombospondin 1von Willebrand FactorADAMTS-13 protein, humanallosteric regulationautoantibodiesprotein conformationvon Willebrand factor

Identifiers

PMID26391536
PMCPMC4778570
OpenAlexW2124912444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.